| Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification S Chidambaranathan-Reghupaty, PB Fisher, D Sarkar Advances in cancer research 149, 1-61, 2021 | 684 | 2021 |
| Current status of gene therapy in hepatocellular carcinoma SC Reghupaty, D Sarkar Cancers 11 (9), 1265, 2019 | 66 | 2019 |
| The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma S Chidambaranathan-Reghupaty, R Mendoza, PB Fisher, D Sarkar Hepatoma research 4, 2018 | 22 | 2018 |
| Mouse bone marrow cell isolation and macrophage differentiation R Mendoza, I Banerjee, D Manna, SC Reghupaty, R Yetirajam, D Sarkar Non-Alcoholic Steatohepatitis: Methods and Protocols, 85-91, 2022 | 18 | 2022 |
| Isolation and culture of mouse hepatocytes and kupffer cells (KCs) R Mendoza, I Banerjee, SC Reghupaty, R Yetirajam, D Manna, D Sarkar Non-Alcoholic Steatohepatitis: Methods and Protocols, 73-84, 2022 | 12 | 2022 |
| Melanoma differentiation associated gene‐9/syndecan binding protein promotes hepatocellular carcinoma D Manna, SC Reghupaty, MDC Camarena, RG Mendoza, MA Subler, ... Hepatology 78 (6), 1727-1741, 2023 | 7 | 2023 |
| Dissecting the balance between metabolic and oncogenic functions of astrocyte‐elevated gene‐1/metadherin Y Rajesh, SC Reghupaty, RG Mendoza, D Manna, I Banerjee, MA Subler, ... Hepatology communications 6 (3), 561-575, 2022 | 7 | 2022 |
| PTER is a N-acetyltaurine hydrolase that regulates feeding and obesity W Wei, X Lyu, AL Markhard, S Fu, RE Mardjuki, PE Cavanagh, X Zeng, ... Nature 633 (8028), 182-188, 2024 | 4 | 2024 |
| Hallmarks of the metabolic secretome SC Reghupaty, NR Dall, KJ Svensson Trends in Endocrinology & Metabolism 35 (1), 49-61, 2024 | 4 | 2024 |
| AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategy SC Reghupaty, R Mendoza, D Sarkar Oncotarget 10 (6), 629, 2019 | 4 | 2019 |
| Hymecromone Promotes Longevity and Insulin Sensitivity in Mice N Nagy, KS Czepiel, G Kaber, D Stefanovski, A Hargil, N Pennetzdorfer, ... Cells 13 (20), 1727, 2024 | | 2024 |
| Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC) SC Reghupaty, S Kanwal, RG Mendoza, E Davis, H Li, Z Lai, ... Cancers 15 (17), 4283, 2023 | | 2023 |
